An Open Label, Randomized, Two-period, Crossover Study to Assess the Effect of Food on Fixed Dose Combination Dapagliflozin/Metformin Tablet (5 mg/1000 mg) in Healthy Male and Female Volunteers.
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2016
At a glance
- Drugs Dapagliflozin/metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 01 Mar 2016 Results published in the Clinical Pharmacology in Drug Development
- 16 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jul 2010 New trial record